Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial
Open Access
- 26 January 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 33 (21), 2662-2671
- https://doi.org/10.1093/eurheartj/ehr505
Abstract
The objective of this study is to ascertain the effects of the left (LV) and right (RV) ventricular lead tip position in response to cardiac resynchronization therapy (CRT). The REVERSE randomized trial examined the effects of CRT in patients with asymptomatic or mildly symptomatic heart failure (HF). We analysed data collected from the active group (CRT-ON) of REVERSE in whom the precise locations of the LV and RV ventricular lead tips were determined from postoperative chest roentgenograms as part of a prespecified sub-study. LV position was classified as lateral or non-lateral, and apical or non-apical. RV position was classified as apical or non-apical. Echocardiographic LV end-systolic volume index (LVESVi), QRS duration, and clinical outcomes at 12–24 months of follow-up were evaluated with respect to the lead tip position. The primary trial endpoint was the proportion of patients with a worsened HF clinical composite response, scored as improved, unchanged, or worsened. Totally 346 patients included in this analysis were followed for a median of 12.6 months (interquartile range: 11.9–23.9 months). The proportion of worsened HF clinical composite response did not correlate with lead position, whereas a significantly greater decrease in the powered secondary endpoint of LVESVi was observed with the non-apical vs. the apical LV lead positions. CRT-paced QRS duration was significantly shorter than at baseline in patients with lateral vs. non-lateral LV position, as well non-apical vs. apical LV position. The incidence of composite endpoint of death and first hospitalization for HF was lower in the LV lateral than in the non-lateral (HR 0.44; 95% CI 0.19–0.99; P= 0.04), and in the LV non-apical than in the apical group (HR 0.27; 95% CI 0.11–0.63; P= 0.001). No significant differences were observed between RV apical and non-apical positions of the lead tip. A more favourable outcome of CRT with regard to LV reverse remodelling and the composite of time to death or first HF hospitalization was observed when the LV lead tip was implanted in the lateral wall, away from the apex, while the position of the RV lead tip was indifferent. The long-term change in QRS duration was significantly associated with the position of the LV lead tip. ClinicalTrials.gov Identifier: NCT00271154.Keywords
This publication has 31 references indexed in Scilit:
- Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) TrialCirculation, 2011
- The effect of left ventricular pacing site on cardiac resynchronization therapy outcome and mortality: the results of a PROSPECT substudyEP Europace, 2010
- Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction: Insights From the European Cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) TrialJournal of the American College of Cardiology, 2009
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in AdultsCirculation, 2009
- Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure SymptomsJournal of the American College of Cardiology, 2008
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapyJournal of Interventional Cardiac Electrophysiology, 2008
- Comparison of stimulation sites within left ventricular veins on the acute hemodynamic effects of cardiac resynchronization therapyHeart Rhythm, 2005
- Epicardial left ventricular lead placement for cardiac resynchronization therapy: optimal pace site selection with pressure-volume loopsThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failureJournal of Cardiac Failure, 2001